[{"Assets_0_FY_USD":1012792000.0,"CIK":"1743881","CommonStockSharesConverted_0_FY_shares":153535084.0,"CommonStockSharesOutstanding_0_FY_shares":147343323.0,"Country":"United States","EarningsPerShareBasic_4_FY_USD":-3.9,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-497934000.0,"NetIncomeLossConverted_4_FY_USD":-562539000.0,"OfficialName":"BridgeBio Pharma Inc. Common Stock","RevenuesConverted_4_FY_USD":69716000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_FY_USD":-867002000.0,"StockholdersEquity_0_FY_USD":-870414000.0,"Ticker":"BBIO","filed":"20220225","footnote":"nan","form":"10-K","fp":"FY","fy":"2021.0","name":"BRIDGEBIO PHARMA, INC.","period":"20211231","qtrs":"0","uom":"USD"}]